GPT and metabolic dysfunction-associated steatotic liver disease: Our group has investigated the suitability of common clinical markers of liver injury, specifically alanine aminotransferase (ALT) and alkaline phosphatase (ALP), as potential diagnostic tools for liver damage induced by chronic low dose administration of MC-LR in the setting of pre-existing NAFLD [75].